Delivery Order SPE2DB20D3101-SPE2DB23FRSG3
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,046.76 for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The contract, awarded by the Defense Logistics Agency (DLA), has a completion date of December 18, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $33,759.18 for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 26, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $7,391.94 for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract was awarded on February 7, 2023, with a completion date of February 8, 2023. The contracting agency is the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $13,383.47 for the supply of HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 29, 2024. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product. The Delivery Order contract, valued at $3,523.32, has a firm fixed-price pricing type and an ultimate completion date of December 17, 2021. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The Delivery Order, valued at $10,633.32, has a firm fixed price and an ultimate completion date of April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Humira (CF) Pen 40 mg/0.4 mls pharmaceutical products. The contract, valued at $3,523.38, was awarded by the Defense Logistics Agency (DLA) on October 30, 2023, with an ultimate completion date of October 31, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,001.98 firm-fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,986.97 for the pharmaceutical product Humira(CF) Pen 40 mg/0.4 mls. The award was made by the Defense Logistics Agency (DLA), a defense agency, on December 26, 2023, with a completion date of December 27, 2023. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $4,732.88 for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 6, 2023. This is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRSG3Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,407.52 for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 21, 2023. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as a primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 7/20/23 |